Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02616406 · ClinicalTrials.gov registry record

Objective Measure of Recovery After Outpatient Surgery

A clinical trial, sponsored by Mayo Clinic.

Completed
Registry status
5
Enrollment target

NCT02616406: Completed study, sponsored by Mayo Clinic.

NCT02616406 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02616406 has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
5 participants
Enrollment target

Study Summary

This is a study using wearable monitoring devices, patient activity and sleep patterns to monitor pre and post operative following outpatient inguinal hernia surgery to determine when these parameters return to baseline.

Interventions

  • DEVICE GENEactiv

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2015-11
Est. Completion 2019-07
Mayo Clinic

2,844 total trials

What the finished NCT02616406 record still lists

NCT02616406 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which GENEactiv is the first listed.

NCT02616406 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02616406 about?

NCT02616406 is a clinical study titled "Objective Measure of Recovery After Outpatient Surgery". This is a study using wearable monitoring devices, patient activity and sleep patterns to monitor pre and post operative following outpatient inguinal hernia surgery to determine when these parameters return to baseline.

What is the current status of trial NCT02616406?

This trial is currently completed. The enrollment target is 5 participants. The study started on 2015-11. Estimated completion is 2019-07.

What interventions are being tested in trial NCT02616406?

The interventions under investigation include: GENEactiv (DEVICE).

Who is sponsoring clinical trial NCT02616406?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02616406, the US trial registry maintained by the National Library of Medicine. NCT02616406 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.